Arbutus Biopharma Corporation
NASDAQ:ABUS
3.73 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 18.141 | 39.019 | 10.988 | 6.914 | 6.011 | 5.9 | 10.7 | 1.5 | 24.873 | 15 | 15.464 | 14.181 | 16.305 | 21.351 | 13.779 | 9.64 | 15.923 | 13.604 | 13.291 | 12.17 | 2.732 | 5.072 | 3.459 | 1.768 | 1.14 | 1.227 |
| Cost of Revenue
| 1.404 | 1.427 | 1.753 | 47.481 | 57.601 | 57.9 | 62.7 | 61.3 | 51.505 | 38.7 | 21.458 | 18.125 | 19.49 | 22.13 | 16.965 | 13.248 | 0 | 6.186 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 16.737 | 37.592 | 9.235 | -40.567 | -51.59 | -52 | -52 | -59.8 | -26.632 | -23.7 | -5.994 | -3.945 | -3.185 | -0.779 | -3.186 | -3.609 | 15.923 | 7.418 | 13.291 | 12.17 | 2.732 | 5.072 | 3.459 | 1.768 | 1.14 | 1.227 |
| Gross Profit Ratio
| 0.923 | 0.963 | 0.84 | -5.867 | -8.583 | -8.814 | -4.86 | -39.867 | -1.071 | -1.58 | -0.388 | -0.278 | -0.195 | -0.036 | -0.231 | -0.374 | 1 | 0.545 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 73.7 | 84.408 | 65.502 | 47.481 | 57.601 | 57.9 | 62.7 | 61.3 | 51.505 | 38.7 | 21.458 | 18.125 | 0 | 22,133,983 | 0 | 0 | 8.43 | 4.526 | 8.763 | 22.316 | 23.706 | 21.609 | 12.849 | 8.716 | 7.746 | 8.651 |
| General & Administrative Expenses
| 22.475 | 17.834 | 17.136 | 14.724 | 17.727 | 16 | 16.1 | 39.4 | 26.438 | 8.7 | 5.546 | 26.893 | 0 | 4.78 | 3.966 | 0 | 4.443 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -1.404 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 21.071 | 17.834 | 17.136 | 14.724 | 17.727 | 16 | 16.1 | 39.4 | 26.438 | 8.7 | 5.546 | 26.893 | 6.183 | 4.78 | 3.966 | 3.619 | 4.443 | 3.853 | 3.785 | 7.757 | 6.785 | 5.525 | 3.101 | 2.255 | 1.567 | 1.33 |
| Other Expenses
| 0.069 | 2.233 | 1.872 | 1.978 | 2.028 | 7.3 | 2.2 | 2.5 | -0.77 | -5.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 94.771 | 102.242 | 82.638 | 64.183 | 77.356 | 76.1 | 80.8 | 101.8 | 78.532 | 47.9 | 27.617 | -19.489 | 7.138 | 11.734 | 5.88 | 4.734 | 13.284 | 9.099 | 14.379 | 35.551 | 37.378 | 32.789 | 19.871 | 10.971 | 9.313 | 9.981 |
| Operating Income
| -78.034 | -65.456 | -73.522 | -57.806 | -144.074 | -89.8 | -110.9 | -491.6 | -102.322 | -33 | -12.153 | -12.992 | -10.323 | -12.513 | -9.066 | -10.949 | 2.639 | -1.681 | -5.958 | -27.635 | -34.646 | -27.717 | -16.412 | -9.203 | -8.173 | -8.754 |
| Operating Income Ratio
| -4.302 | -1.678 | -6.691 | -8.361 | -23.968 | -15.22 | -10.364 | -327.733 | -4.114 | -2.2 | -0.786 | -0.916 | -0.633 | -0.586 | -0.658 | -1.136 | 0.166 | -0.124 | -0.448 | -2.271 | -12.681 | -5.465 | -4.744 | -5.206 | -7.167 | -7.132 |
| Total Other Income Expenses Net
| 5.185 | 0.444 | -2.725 | -5.939 | -22.305 | 6 | -38.6 | -388.8 | -24.321 | -5.8 | -2.451 | -3.814 | 0.468 | -0.007 | -0.416 | -4.114 | -6.244 | 19.443 | -4.731 | -2.168 | 0 | 0 | 0.455 | 0 | 0 | 0 |
| Income Before Tax
| -72.849 | -65.012 | -76.247 | -63.745 | -166.379 | -61.4 | -108.7 | -489.1 | -77.306 | -38.7 | -14.064 | 29.948 | -9.855 | -12.52 | -9.482 | -11.718 | -2.583 | 18.078 | -7.671 | -29.802 | 0 | 0 | -15.956 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -4.016 | -1.666 | -6.939 | -9.22 | -27.679 | -10.407 | -10.159 | -326.067 | -3.108 | -2.58 | -0.909 | 2.112 | -0.604 | -0.586 | -0.688 | -1.216 | -0.162 | 1.329 | -0.577 | -2.449 | 0 | 0 | -4.612 | 0 | 0 | 0 |
| Income Tax Expense
| -0 | 4.444 | 1.104 | 1.466 | -12.656 | -4.3 | -24.3 | -105 | -16.185 | 0.1 | 1.911 | 3.722 | -0.591 | -0.1 | 0.26 | 3.376 | 0 | -0.002 | 0.388 | 8.946 | -0.484 | -0.852 | -2.327 | 0 | 0 | 0 |
| Net Income
| -72.849 | -69.456 | -77.351 | -65.211 | -153.723 | -57.1 | -84.4 | -384.1 | -61.121 | -38.8 | -14.064 | 29.948 | -9.733 | -12.413 | -9.326 | -11.718 | -2.583 | 18.081 | -8.059 | -28.05 | -34.076 | -26.794 | -14.015 | -9.203 | -8.173 | -8.754 |
| Net Income Ratio
| -4.016 | -1.78 | -7.04 | -9.432 | -25.574 | -9.678 | -7.888 | -256.067 | -2.457 | -2.587 | -0.909 | 2.112 | -0.597 | -0.581 | -0.677 | -1.216 | -0.162 | 1.329 | -0.606 | -2.305 | -12.473 | -5.283 | -4.051 | -5.206 | -7.167 | -7.132 |
| EPS
| -0.44 | -0.46 | -0.73 | -0.86 | -2.69 | -1.03 | -1.54 | -7.24 | -1.34 | -1.8 | -0.92 | 2.16 | -0.86 | -1.2 | -0.9 | -1.44 | -0.54 | 4.68 | -1.04 | -3.64 | -4.78 | -4.08 | -2.76 | -1.87 | -2.9 | -4.05 |
| EPS Diluted
| -0.44 | -0.46 | -0.73 | -0.86 | -2.69 | -1.03 | -1.54 | -7.24 | -1.34 | -1.73 | -0.92 | 2.07 | -0.86 | -1.2 | -0.9 | -1.44 | -0.54 | 4.68 | -1.04 | -3.64 | -4.78 | -4.08 | -2.76 | -1.87 | -2.9 | -4.05 |
| EBITDA
| -76.63 | -61.031 | -71.523 | -57.095 | -89.555 | -63.3 | -27.3 | 292.1 | -29.519 | -32.4 | -9.089 | 38.354 | -9.836 | -11.468 | -6.736 | -3.113 | 4.073 | -0.961 | 6.041 | -15.736 | -27.759 | -22.061 | -12.946 | -7.946 | -6.868 | -7.764 |
| EBITDA Ratio
| -4.224 | -1.564 | -6.509 | -8.258 | -14.899 | -10.729 | -2.551 | 194.733 | -1.187 | -2.16 | -0.588 | 2.705 | -0.603 | -0.537 | -0.489 | -0.323 | 0.256 | -0.071 | 0.455 | -1.293 | -10.16 | -4.35 | -3.742 | -4.494 | -6.023 | -6.326 |